Cardio Diagnostics Holdings Inc
CDIOW0.030USD
-0.009-23.86%
Cierre 04/25, 16:00（ET）Cotizaciones retrasadas 15 min
--Cap. mercado
--P/E TTM
Información de Cardio Diagnostics Holdings Inc Compañía
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
Información de la empresa
Código de la empresaCDIOW
Nombre de la empresaCardio Diagnostics Holdings Inc
Fecha de salida a bolsaNov 23, 2021
Fundada en2021
Director ejecutivoDr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Número de empleados- -
Tipo de títulosCompany Warrant
Fin del año fiscal- -
Dirección311 W. Superior Street
CiudadCHICAGO
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal60645
Teléfono18552269991
Sitio Web
Código de la empresaCDIOW
Fecha de salida a bolsaNov 23, 2021
Fundada en2021
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionados
Cambio
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Mr. Paul Burton, J.D.
Mr. Paul Burton, J.D.
Independent Director
Independent Director
--
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
--
--
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
Mr. Paul Burton, J.D.
Mr. Paul Burton, J.D.
Independent Director
Independent Director
--
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionados
Cambio
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Mr. Paul Burton, J.D.
Mr. Paul Burton, J.D.
Independent Director
Independent Director
--
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
--
--
Desglose de ingresos
No datos encontrados
No datos encontrados
Por negocio
Por región
No datos encontrados
Accionista
Hora de actualización: mié., 2 de abr
Hora de actualización: mié., 2 de abr
Estadísticas de accionistas
Tipo
Estadísticas de accionistas
Accionista
Proporción
Other
100.00%
Estadísticas de accionistas
Accionista
Proporción
Other
100.00%
Tipo
Accionista
Proporción
Other
100.00%
Participación institucional
Hora de actualización: lun., 3 de mar
Hora de actualización: lun., 3 de mar
Periodo de informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
21
580.02K
0.00%
-815.90K
2024Q4
27
580.02K
0.00%
-1.17M
2024Q3
29
968.76K
0.00%
-800.56K
2024Q2
31
932.85K
0.00%
-1.50M
2024Q1
31
1.20M
0.00%
-1.20M
2023Q4
31
1.25M
0.00%
-1.14M
2023Q3
31
1.30M
0.00%
-1.11M
2023Q2
31
1.31M
0.00%
-1.11M
2023Q1
31
1.36M
0.00%
-1.02M
2022Q4
28
1.68M
0.00%
-569.48K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
DoubleLine Capital LP
--
0%
-11.64K
-100.00%
Mar 31, 2024
Virtu Americas LLC
--
0%
-14.51K
-100.00%
Jun 30, 2024
Walleye Trading, LLC
--
0%
-132.26K
-100.00%
Dec 31, 2024
RiverNorth Capital Management LLC
--
0%
-39.83K
-100.00%
Mar 31, 2024
AQR Arbitrage, LLC
--
0%
-2.79K
-100.00%
Dec 31, 2023
Susquehanna International Group, LLP
--
0%
-25.99K
-100.00%
Jun 30, 2024
Castle Creek Arbitrage, LLC
--
0%
-11.71K
-100.00%
Sep 30, 2023
Citadel Advisors LLC
--
0%
-11.63K
-100.00%
Dec 31, 2024
UBS Financial Services, Inc.
--
0%
-9.74K
-100.00%
Dec 31, 2024
Ver más
ETF relacionados
Nombre
Proporción
No datos encontrados
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
No datos encontrados
División de acciones
Fecha
Tipo
Relación
No datos encontrados
Fecha
Tipo
Relación
No datos encontrados